Latest Breaking News On - Sun yat sen university cancer - Page 1 : comparemela.com

InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China

InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesChunhua luInnocare pharmaSun yat sen university cancer centerCare pharmaSun yat sen university cancer

AI model helps diagnose ovarian cancer - China Daily » Capital News

AI model helps diagnose ovarian cancer - China Daily » Capital News
capitalfm.co.ke - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capitalfm.co.ke Daily Mail and Mail on Sunday newspapers.

Cai guangyaoLiu jihongTongji hospital of huazhong university scienceSun yat sen university cancer centerSun yat sen universityLancet digital healthZhejiang universityTongji hospitalHuazhong universitySun yat sen university cancer

Coherus BioSciences (CHRS) and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02

Coherus BioSciences (CHRS) and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRuihua xuRosh diasJianjun zouJunshi biosciencesRobert ferrisEndocrinopathiesadrenal insufficiencyJournal of the american medical associationAmerican society of clinical oncologistsAdministration in prescribing informationShanghai junshi biosciences co ltdGlobal researchCoherus biosciences incDrug administrationHillman cancer centerSun yat sen university cancer centre

Coherus and Junshi Biosciences Announce Publication of Positive Final Overall Survival Results of JUPITER-02, a Phase 3 Trial Evaluating LOQTORZI™ (toripalimab-tpzi) as Treatment for Nasopharyngeal Carcinoma, in the Journal of the American Medical Association

– Final overall survival analysis of the JUPITER-02 trial shows first-line treatment with LOQTORZI plus chemotherapy significantly prolongs survival in patients with recurrent or metastatic NPC.

United statesJunshi biosciencesJudy steckerJami taylorCoherus biosciencesZhi liRobert ferrisRuihua xuRosh diasJianjun zouHill knowltonIr teamCoherus biosciences incAdministration in prescribing informationPr teamHillman cancer center

Larger lymph node threshold helps facilitate better risk stratification and treatment decisions in nasopharyngeal carcinoma

According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma (NPC).

United statesZhiying liangMegan craigAmerican joint committee on cancerChina sun yat sen university cancer centerAmerican journalAmerican joint committeeSun yat sen university cancerLymph node